Related Experiment Video
Updated: Sep 27, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
[Psoriasis therapy with biologicals]
1Abt. Dermatologie, Venerologie und Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel. umrowietz@dermatology.uni-kiel.de
Abstract:
"Biologicals" represent a new group of compounds which are produced by using methods of biotechnology. They mainly include monoclonal antibodies, fusion proteins and recombinant proteins. The development of biologicals is based on the knowledge derived from pathogenetic studies in psoriasis which have focussed on targeting cell- or mediator-systems relevant for the disease. In this regard, the inactivation of soluble mediators such as tumor-necrosis-factor alpha, the blockade of receptors for cytokines such as interleukin 2, and the interference with T cell activation by antigen presenting cells are all of increasing importance. Recombinant cytokines such as interleukins 4 or 10 are able to modulate the immunological balance. Blockade of adhesion molecules to prevent extravasation of inflammatory cells is a new strategy under development. This article reviews about the current knowledge of psoriasis therapy with biologicals.
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drug Products: Biologics, Biosimilars and Interchangeables
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...